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Background: Despite the years of experience in percutaneous
transseptal mitral commissurotomy (PTMC), development of
mitral regurgitation (MR) remains a dreaded complication, the
incidence of which has been described between 1.4% and 7.5%.
The aim of present study is to ﬁnd out predictors of the develop-
ment of moderate to severe mitral regurgitation (MR) following
PTMC using Accura balloon technique at our Institute.
Methods:Weretrospectively studied1638consecutivepatientswith
rheumatic MS who were subjected to PTMC using Accura balloon
between January 1, 2013 to December 31, 2014. Inclusion criteria for
the study were symptomatic MS with NYHA functional class II or
more with mitral valve area (MVA) ≤1.5 cm with less than conco-
mitant grade 2 MR and severe MS with mild aortic regurgitation in
sinus rhythm or AF. Exclusion criteria were patients with concomi-
tant moderate MR or aortic regurgitation (AR) of grade II/IV ormore,
and presence of left atrial (LA) thrombi assessed by TEE done on day
of theprocedure inpatientswithAF,h/oCVA,orRVdysfunction,and
within a week of scheduled procedure if otherwise. Patients were
divided into two groups according to the development of moderate
to severe MR or not: Group A (patients without MR/mild MR post
PTMC) and Group B (patients who developed signiﬁcant grades of
post-PTMC MR). According to the severity of MR, we divided our
patients into two groups (Group A, patients without MR/Mild MR,
and Group B, patients with higher grades of hemodynamically
signiﬁcant moderate-severe and severe MR). There were no signiﬁ-
cant baseline differences between both groups with regards to their
clinical characteristics, echocardiographic measurements other
than MV scoring, and number of inﬂations.
Transthoracic echocardiographic and Doppler examinations were
done within a week before intervention and within one day after
the procedure. We studied mitral valve morphology using the
Massachusetts General Hospital score by Wilkins et al., and also
included other parameters such as severity of IAS bulge toward RA,
and irregular thickening of leaﬂet, and presence of calciﬁed
nodules on mitral valve leaﬂets. PTMC using Accura balloon was
done with the standard trans-septal technique. We also measured
mitral valve area (MVA), transmitral mitral valve gradient (MVG),
pulmonary artery systolic pressure (PASP) and presence and sever-
ity of pre- and post-PTMC MR. Severity of MR was determined by
expressing the ratio of maximal jet area to left atrial area in the
same view using color ﬂow mapping and graded from one to four
according to standard ACC/ESC criteria and other quantitative
measures such as vena contracta or PISA in cases of ambiguity.
Development of new moderate to severe MR was deﬁned as the
increase of ≥2/4 grades of MR. Echo Doppler classiﬁed MR as
whether due to leaﬂet tear (partial or complete), and commissural
MR, and chordal rupture (partial or complete). Multiple stepwise
logistic regression analysis was performed for variables found
positive on univariate analysis to determine the most important
predictor(s) of developing moderate to severe MR. Data were col-
lected using SPSS version 16 and ‘‘p’’ values were considered
signiﬁcant if it were <0.05.
Results: 40 patients (%) developed moderate-to-severe MR, and 21
patients (%) severe MR, with 13 patients needing immediate sur-
gery for hemodynamic instability and 14 more undergoing surgery
within 48 hours to 24 months, latter especially commissural MR.
Thus the incidence of postprocedure moderate-to-severe MR and
severe MR in our study was 2.1% and 1.2%, respectively, and 3.3%
overall.
A tear of the AML in 10 patients (incomplete in 4) and a tear of the
posterior leaﬂet occurred in 4 patients (incomplete in 3). Thus 7
patients developed ﬂail leaﬂet. 2 patient had total chordal rupture
(needing immediate surgery) with 6 patients developing partial
chordal tears, none of which was sent for surgery. The majority of
the remainder of 25 patients developed various grades of signiﬁ-
cant commissural MR, 8 of whom were sent for surgery. On ana-
lysing Group B patients, female (v/s male) gender, presence of
calciﬁc nodules on leaﬂets, presence of AF in the patient before
PTMC, higher degree of IAS bulge causing a lower site of IAS
puncture and irregular thickening of valve leaﬂet (all with
p > 0.05), were all signiﬁcantly higher than group A patients and
were associated with the development of severe post-PTMC MR.
There was a trend towards more MR in patients with previous
PTMC/CMV done ( p = 0.12), and higher age of the patient ( p = 0.81).
Conclusion: Using the Wilkins score and the other anatomical
variables, we found that the best predictive factor with multiple
regression analysis for the risk of signiﬁcant MR after BMV with
Accura balloon is the combination of irregular thickening of leaﬂet
and presence of calciﬁc nodules, in presence of bulging IAS with
predictive percentage of 85.7%. Higher grades of subvalve ﬁbrosis
tended to give a poorer MVA post PTMC, but were not associated
with higher grades of post-PTMC MR.
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Aim: To study the procedural success of percutaneous mitral
commissurotomy (PMC) and one month outcomes in patents with
mitral valvular calciﬁcation.
Methods and results: Over a period of 13 months we enrolled 103
patients who underwent PMC in our institution. All patients were
screened for ﬂuoroscopic calcium and divided into two groups:
group 1 without signiﬁcant calcium (no calcium or calcium seen
in cine ﬂuoroscopy) and group 2 with signiﬁcant calcium (calcium
seen in high ﬂuoroscopy). There were 85 patients in group 1 and 18
patients in group 2 and procedural success was 91.8% and 72%
respectively in two groups (P = 0.034). Conﬁdence interval of proce-
dural success in calciﬁc group was 51.5–92.9%. In this study, the
presence of mitral calcium detected by echocardiography or cine
ﬂuoroscopy did not inﬂuence the immediate success of PMC. There
was no procedural death and none developed severe mitral regur-
gitation (MR) or requiredmitral valve surgerywithin onemonthpost
procedure. Other parameter that inﬂuencedprocedural successwas
Wilkins score >8. All patients except two improved symptoms to
New York Heart Association (NYHA) I/II at one month follow-up.
Conclusion: PMC success rate in patients with signiﬁcant ﬂuoro-
scopic calcium is inferior to those without signiﬁcant calciﬁcation.
Still the success rate in calciﬁc group is good without additional
complication.
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Background:Myocardialﬁbrosisoccurs inaorticstenosis (AS)aspart
of the hypertrophic response. It can be detected by late gadolinium
enhancement (LGE), which is associated with an adverse prognosis
in the form of increased mortality and morbidity.
Objectives: To assess the prevalence of LGE patterns using cardiac
magnetic resonance (CMR) in severe AS patients and to study the
prognostic signiﬁcance of LGE pertaining to mortality, arrhythmic
risk, heart failure/hospitalization and LV ejection fraction fall ≥20%.
Methods: Patients were enrolled into the study from June 2012 to
November 2014. All the patients underwent CMR and various
patterns of enhancement were studied. These patients if sympto-
matic were advised aortic valve replacement (AVR) and others
were managed conservatively. All patients were followed up and
watched for outcomes like mortality, heart failure/hospitalization
for cardiovascular cause, fall in left ventricular ejection fraction
(LVEF) ≥20% and arrhythmia.
Results: A total of 109 patients (mean age  57.7  12.5 yrs) under-
went CMR with 63 males. These patients were followed up for a
mean of 13months. Among 38 patientswho underwent AVR, 6 died
(5 – cardiovascular cause, 1 – non cardiovascular). 71 patients were
managed conservatively out of which 18 died (17 – cardiovascular
cause, 1 – non cardiovascular cause). LGE patterns were seen in 46
patients (43%); midmyocardial enhancement was seen in 31.1% of
cases (33 patients). No LGE pattern was seen in 57% (63 patients).
Basal and mid regions were maximally involved with mid myocar-
dial enhancement in 66% & 68.3% respectively. LV ejection fraction
(p = 0.002), peak aortic systolic velocity (p = 0.01) and peak aortic
systolic gradient (p = 0.02) were the main predictors of LGE. Main
predictors of primaryoutcomewereNYHAclass [OR – 13.4 (2.8–26.1),
p ≤ 0.001], age – 62 9.6 yrs (p = 0.001), EF simpson-50.9  13%
(p ≤ 0.001), LGE [OR 2.8 (1.27–6.47), p = 0.01], number of segments
involved [2.37  2.1, p ≤ 0.001] & CMR LV mass (151.73 32 g,
p = 0.007). LGE truly predicted heart failure/hospitalization for car-
diovascular cause [OR – 3.8 (1.2–11.9), p = 0.01] and fall in LVEF [OR –
5.8 (1.5–22.5), p = 0.005]. Patients with LGE had 2.87 times risk of
adverse outcomes and patients with more than 3 segment LGE
involvement had again increased chances of adverse outcomes.
Conclusions: LGE was detected by CMR in 43% of patients with
severe AS. It predicted recurrent heart failure, hospitalization for
cardiovascular cause and fall in LV ejection fraction. Our study has
laid a path to larger prospective studieswith long term follow-up to
assess the prognostic impact of CMR in patients with severe AS.
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Background: Early surgery could be advisable in selected patients
with chronic severemitral regurgitation, but there are no criteria to
identify candidates who could beneﬁt from this strategy. In
patients with primary mitral regurgitation (MR), BNP is known
to be a good surrogate marker of MR consequences on the left
ventricle, left atrium, and systolic pulmonary arterial pressure
(PAP), and is a powerful predictor of outcome. It is hypothesized
that the measurement of BNP at exercise could provide incremen-
tal value as compared with standard resting BNP for the risk
stratiﬁcation of patients with asymptomatic MR.
Methods and results: Comprehensive resting and exercise trans-
thoracic Doppler echocardiography was performed in 50 consecu-
tive asymptomatic patients with moderate to severe MR and
preserved left ventricular (LV) function enrolled over a period of
12 months from October 2013 to October 2014. Blood samples were
collected both at rest andduring exercise. Follow-upwasdone every
3 months for 1 year. The BNP level signiﬁcantly increased from rest
to exercise) in 16 patients. There was a signiﬁcant graded relation-
ship between increasing BNP level at exercise (according to tertiles)
and increased incidence of cardiac events (death, heart failure,
mitral valve surgery driven by symptoms, or LV dilatation/dysfunc-
tion onset) (1 year, 10 5% vs. 20 6% vs. 40.5  9 in tertiles 1, 2 and
3, respectively). On multivariable analysis, after adjustment for
demographic and echocardiographic data and for resting BNP level,
exercise BNP remained signiﬁcantly associated with increased risk
of cardiac events during the follow-up (hazard ratio 2.6 and 3.8,
P = 0.040 and 0.020, for tertiles 2 and 3, as compared with tertile 1).
Conclusions: In asymptomatic patients with primary MR, exercise
BNP level provides incremental prognostic value beyond what is
achieved by demographic and echocardiographic data and resting
BNP level. Patients with elevated exercise BNP should be consid-
ered at high risk of reduced cardiac event-free survival.
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